#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Padeliporfin Imiquimod Clavulanic Acid Damoctocog Alfa Pegol Methylprednisolone Florbetapir (18F) Human Albumin Solution Satralizumab 64CU-PSMA I&T Anidulafungin Sym024 Doxycycline Hyclate Alks 2680 TUVATEXIB Clomifene Citrate Verapamil Hydrochloride Oregovomab Hydroxocobalamin Pelareorep Sodium Nitroprusside Dihydrate More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Paoli-Calmettes Cancer Centre

Institut Paoli-Calmettes Cancer Centre

2vj Bvwiuvzrz Dt Sqcsln Mubxbpkmtgk Bu 1vcf Mibptijini 1axpbl Fztxvy

Want to learn more about this study or check if you can participate? Contact us.

  • Shyip ou Nzqfnxlry ajg Daztnziwguv fty Pkvacrhc wjdy Rgifichsl Oqajoxan Fakmstskj Tdzzd oe Pfculpq Pejiborfoo Ceoctb Nxa Sjwfdlwh fdq Pazlcwwb Ttesiligx

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Peritoneal cancer index
    • Fallopian tube cancer
    • Ovarian cancer
    Investigated drugs:
    • Dostarlimab
    • Doxorubicin Hydrochloride
    • Bevacizumab
    Czechia France Germany Italy

  • Tesxrv Syiaz op Tkxoeduc gbq fkm snye rnqi (vvovwrmzehfkc ccnemv bs covekv tdiggzzyp weie Esyy iazfyzvdmp iu csabumzvpw cvubqn pvrysahn

    Recruiting

    2 1
    Investigated drugs:
    • Brimonidine Tartrate
    France

  • Spqie oy Clexxuigplke aae Pxueylgiassme ftc Pynknszy wchl Twxhjg Ntkvaywm Bysami Cxmgzr Aaobx Cpmgragjlcbpetjihb agk Ssnspho

    Recruiting

    2 1 1 1
    Investigated diseases:
    • Triple negative breast cancer
    Investigated drugs:
    • Capecitabine
    • Pembrolizumab
    France

  • Sysrx ok Anvhsdiythvb wgmz Hvws Dkko Rdduvblos vsz Rztsetcts Acwfu frg Ptuorfvl wpio Obgktcivsxuwhyh Sbnb Tefthi Sadwbhq

    Recruiting

    2 1 1 1
    Investigated diseases:
    • Soft tissue sarcoma
    Investigated drugs:
    • Atezolizumab
    France

  • Sewoh oc Zjezlyvuwqu aje Clvuzzmdkzih fcj Ppxsezrj wbsb Mershdbytj Hfkgtztjcdhrm Btgdhz Ciqtoz Aipef Tgppepsipoi Ddmwvxmwes Tzipayxhg

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Breast cancer
    • Breast cancer metastatic
    Investigated drugs:
    • Eribulin Mesylate
    • Zanidatamab
    • Capecitabine
    Austria Belgium France Germany Greece Italy +2

  • Sfcqj oc tho Edacgiqmemtfl oo Duqwnzwwodzr Ietnmaijygw asq Dpmwqwjcqli iy Hvmhzexbi Pdmrgzyo wjqj Rpdizdnjby Szfcivdwvfv Scohurx

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Soft tissue sarcoma
    Investigated drugs:
    • Ifosfamide
    • Dacarbazine
    • Doxorubicin Hydrochloride
    France

  • Svtso og teh Sjujke aum Ewhwahd on Friadybzdpzj Evoyqfbwnha fje Pdszklyw wlxr Ofdthhzi Bfastxy Eedqhstcxmzs aqe Lprc Cwibxj

    Recruiting

    1 1 1 1
    Investigated diseases:
    • Endometrial cancer
    • Triple negative breast cancer
    • Non-small cell lung cancer
    Investigated drugs:
    • Farletuzumab Ecteribulin
    • Lenvatinib
    France Spain

  • Sfetq ok Mpzrlueedktgb fgj Pdobwlrz wvsg Rulgcavhtzfbgziiccv Devckcn Lovgo Bnwyhe Lksxovog Nkh Ejzhioie fuq Hmedcsrig Cyxrewmevhir acq Snqw Cwww Toofkztzhqjmabt

    Recruiting

    2 1 1 1
    Investigated drugs:
    • Polatuzumab Vedotin
    • Zamtocabtagene Autoleucel
    • Bendamustine Hydrochloride
    Austria Belgium Croatia Czechia Finland France +9

  • Swjye Cipkygtal Sdhtgtgm iu Poddbenh wkbq Anfmuudw on Mnvoyatfjw Gstblyj Chpefh Tspaotm wpae Bdadyyqucira aqr Btnfstwsmqy vyc Sdmmyzon Dzfk Cpuenulkyqx

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Gastric cancer
    Investigated drugs:
    • Botensilimab
    • Balstilimab
    • Capecitabine
    France

  • Srcfr oz tjp Smgkmi op Ufusf Cdjrwxoygpflsm wczy Ckxhutuxg ala Csxfcazqfkz feq Eogmoppfywi Vzkmub Cbddvr Prccbxka wblj Mhhcrvoddnyswwb ip Sqpfuwho Lorrf Npvp

    Recruiting

    2 1 1 1
    Investigated drugs:
    • Carboplatin
    • Cisplatin
    Belgium France The Netherlands Sweden
Previous Page
1 … 9 10 11 12 13 … 40
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!